Press releases and News

2022-11-15 10:00 Regulatory
Uppsala, November 15, 2022. Senzime AB (publ) will give an update at today’s investor event on the strategy following the acquisition of Respiratory Motion (RMI), present the growth opportunities in the market given the new US and European clinical...
2022-11-10 08:30 Regulatory Interim
Press release: Uppsala, 10 November 2022. Senzime AB's (publ) interim report for January - September 2022 is now available on the company's website www.senzime.com. Financial information July - September 2022 Financial information January - September...
2022-08-31 17:06 Regulatory
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 31 August 2022 by voting in advance, whereby the shareholders primarily resolved on the following matter. Board of directors The...
2022-08-18 07:55 Regulatory
Press release: Uppsala, August 18, 2022. Senzime today announces that the company’s TetraGraph® -system has now received FDA 510k-clearance for use in children with the disposable sensor TetraSens Pediatric. Senzime can thus broaden the indication...
2022-08-02 09:20 Regulatory
The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on Wednesday 31 August 2022. The board of directors has decided in accordance with the Swedish Act on Temporary...
2022-08-01 11:00 Regulatory
Press release: Uppsala, 1 August 2022 Senzime AB (publ) (“Senzime” or the “Company”) publishes a prospectus for admission to trading of newly issued shares on Nasdaq Stockholm in connection with the acquisition of Respiratory Motion...
2022-07-15 08:45 Regulatory Interim
Press release: Uppsala, 15 July, 2022. Senzime AB's (publ) interim report for January - June 2022 is now available on the company's website www.senzime.com. Financial information April - June 2022 • Net sales amounted to SEK 3,403 thousand (4,390)...
2022-07-01 18:00 Regulatory
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE...
2022-06-27 11:30 Regulatory
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 27 June 2022 by voting in advance, whereby the shareholders primarily resolved on the following matter. Authorization to the board...
2022-06-21 08:30 Regulatory
Press release: Uppsala, June 21, 2022. Senzime today announces that they have signed a license and connectivity agreement with Masimo, a US-headquartered and global leader in patient monitoring solutions. With the agreement a new dedicated module is to...

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.